<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.baystatetimes.com/article/909711133-wayside-youth-family-support-network-earns-prestigious-2026-usa-today-top-workplaces-award-for-fourth-consecutive-year</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T19:34:45+00:00</news:publication_date>
        <news:title>Wayside Youth &amp; Family Support Network Earns Prestigious 2026 USA TODAY Top Workplaces Award for Fourth Consecutive Year</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/907745187-realciso-launches-2-0-rebuilding-compliance-platform-around-program-maturity-instead-of-checklists</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T11:00:00+00:00</news:publication_date>
        <news:title>RealCISO Launches 2.0, Rebuilding Compliance Platform Around Program Maturity Instead of Checklists</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24840355-realciso-logo-2679x500.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909739339-spyre-therapeutics-announces-grants-of-inducement-awards</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:28:07+00:00</news:publication_date>
        <news:title>Spyre Therapeutics Announces Grants of Inducement Awards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909738988-great-elm-capital-corp-gecc-schedules-first-quarter-2026-earnings-release-and-conference-call</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:15:00+00:00</news:publication_date>
        <news:title>Great Elm Capital Corp. (“GECC”) Schedules First Quarter 2026 Earnings Release and Conference Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c67af62e-a4ad-40ad-84f3-30e505895084/small/gecc-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909739233-roblox-investigated-for-securities-fraud-block-leviton-encourages-investors-who-have-lost-money-to-contact-the-firm-to-recover-losses</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:07:15+00:00</news:publication_date>
        <news:title>Roblox Investigated for Securities Fraud; Block &amp; Leviton Encourages Investors Who Have Lost Money to Contact the Firm to Recover Losses</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909738836-solid-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:05:00+00:00</news:publication_date>
        <news:title>Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909738914-candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:05:00+00:00</news:publication_date>
        <news:title>Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909732252-intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:01:00+00:00</news:publication_date>
        <news:title>Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909732282-avalyn-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:01:00+00:00</news:publication_date>
        <news:title>Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909698743-general-catalyst-global-resilience-merger-corp-announces-closing-of-402-5-million-initial-public-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T17:33:00+00:00</news:publication_date>
        <news:title>General Catalyst Global Resilience Merger Corp. Announces Closing of $402.5 Million Initial Public Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NDUwYmU4YjMtOWIwYS00OTkxLWEzOWEtNjMxYjkxOGY3YWFkLTUwMDE2MTgwMS0yMDI2LTA1LTAxLWVu/tiny/General-Catalyst-Global-Resili.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909662699-membrane-and-filtration-market-to-reach-591-2-billion-by-2030-driven-by-climate-change-infrastructure-investments</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T14:38:49+00:00</news:publication_date>
        <news:title>Membrane and Filtration Market to Reach $591.2 Billion by 2030, Driven by Climate Change Infrastructure Investments</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909631788-damora-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T12:00:00+00:00</news:publication_date>
        <news:title>Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/547722cf-495b-4464-97a9-35bea3fa5d15/small/damora-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909624234-molecular-partners-publishes-phase-1-mp0317-data-in-nature-cancer-demonstrating-tumor-localized-cd40-activation-and-tumor-microenvironment-remodeling</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T11:00:00+00:00</news:publication_date>
        <news:title>Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909620212-rhythm-pharmaceuticals-announces-imcivree-setmelanotide-granted-marketing-authorization-by-european-commission-for-the-treatment-of-obesity-and</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T10:55:00+00:00</news:publication_date>
        <news:title>Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/908799153-bentley-university-joins-the-learningwell-coalition-through-bentleyplus-initiative</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T19:45:24+00:00</news:publication_date>
        <news:title>Bentley University Joins the LearningWell Coalition Through BentleyPlus Initiative</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909151974-electra-ai-s-head-of-marketing-giovanni-rossi-joins-volta-foundation-s-applied-ai-data-center-infrastructure-committee</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T16:45:40+00:00</news:publication_date>
        <news:title>ELECTRA AI&#39;s Head of Marketing Giovanni Rossi joins Volta Foundation&#39;s Applied AI &amp; Data Center Infrastructure Committee</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24844827-giovanni-rossi-vf-committee-ai-1456x761.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909363664-strategies-for-youth-s-policing-the-teen-brain-program-earns-rigorous-iadlest-seal-of-excellence-recertification</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T15:26:35+00:00</news:publication_date>
        <news:title>Strategies for Youth’s Policing the Teen Brain Program Earns Rigorous IADLEST Seal of Excellence Recertification</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24294604-sfy-s-policing-the-teen-brain-1200x628.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909226766-aptia-earns-two-silver-stevie-awards-in-the-24th-annual-american-business-awards-for-customer-service-excellence</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T14:00:00+00:00</news:publication_date>
        <news:title>Aptia Earns Two Silver Stevie® Awards in The 24th Annual American Business Awards® for Customer Service Excellence</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909070673-rtsws-honors-2026-woman-of-the-year-kristie-feinberg-of-manulife-john-hancock-investments-during-finlit-month</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T13:59:54+00:00</news:publication_date>
        <news:title>RTSWS Honors 2026 Woman of the Year Kristie Feinberg of Manulife John Hancock Investments during FinLit Month</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24844021-student-step-and-repeat-2000x1042.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/907840430-maverick-brands-one-of-america-s-top-digital-capital-raising-firms-deploys-proprietary-ai-stack-for-issuers</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T13:20:57+00:00</news:publication_date>
        <news:title>Maverick Brands, One of America’s Top Digital Capital Raising Firms, Deploys Proprietary AI Stack for Issuers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24115040-maverick-brands-millions-rais-1201x1201.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909331226-integral-biosystems-to-present-on-the-nanom-wafer-technology-at-arvo-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T12:44:03+00:00</news:publication_date>
        <news:title>Integral BioSystems to Present on the NanoM-Wafer Technology at ARVO 2026</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909330944-next-level-now-announces-trademark-for-rotru-framework-transforming-profitability-for-it-managed-service-providers</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T12:20:06+00:00</news:publication_date>
        <news:title>Next Level Now Announces Trademark for ROTRU™ Framework, Transforming Profitability for IT Managed Service Providers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24269558-logo-680x120.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909478424-hemab-therapeutics-announces-pricing-of-upsized-initial-public-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T22:55:19+00:00</news:publication_date>
        <news:title>Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ODA2NTAwNWItYjg4Mi00M2QxLTk5MGMtYWQwYjJlMGZiNzYzLTEzMjE4MjEtMjAyNi0wNC0zMC1lbg==/tiny/Hemab-Therapeutics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909446058-cue-biopharma-announces-30-million-private-placement</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T20:25:00+00:00</news:publication_date>
        <news:title>Cue Biopharma Announces $30 Million Private Placement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909446064-cue-biopharma-expands-pipeline-with-exclusive-license-from-ascendant-health-sciences-ltd-for-clinical-stage-dual-mechanism-anti-ige-antibody</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T20:15:00+00:00</news:publication_date>
        <news:title>Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909446147-boston-beer-reports-first-quarter-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T20:15:00+00:00</news:publication_date>
        <news:title>Boston Beer Reports First Quarter Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e9d20586-4ab8-41f4-8a2b-7e77498053ca/small/bbc-logo-final-08122019-02-1706629452322-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909437987-akebia-therapeutics-to-report-first-quarter-2026-financial-results-and-discuss-recent-business-highlights</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T20:05:00+00:00</news:publication_date>
        <news:title>Akebia Therapeutics to Report First Quarter 2026  Financial Results and Discuss Recent Business Highlights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909438371-cue-biopharma-names-shao-lee-lin-m-d-ph-d-ceo-president-and-board-director-to-lead-continued-growth-and-transformation-into-a-clinical-stage</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T20:05:00+00:00</news:publication_date>
        <news:title>Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909423101-earned-and-bat-boys-team-up-for-second-baseball-collaboration-featuring-top-prospect-angel-genao-veteran-manager-greg-dicenzo-and-earned-founders</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T19:02:11+00:00</news:publication_date>
        <news:title>EARNED and Bat Boys Team Up for Second Baseball Collaboration Featuring Top Prospect Angel Genao, Veteran Manager Greg DiCenzo, and EARNED Founders</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f57eca91-0c03-4f37-868f-8a6053e5ce69/medium/angel-genao-and-bat-boys.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909423029-check-point-software-technologies-ltd-investigated-for-securities-fraud-investors-should-contact-block-leviton-to-find-out-how-they-might-recover</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T18:51:52+00:00</news:publication_date>
        <news:title>Check Point Software Technologies Ltd. Investigated for Securities Fraud; Investors Should Contact Block &amp; Leviton to Find Out How They Might Recover Losses</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909408923-kadant-to-hold-earnings-conference-call-on-wednesday-may-6-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T18:02:01+00:00</news:publication_date>
        <news:title>Kadant to Hold Earnings Conference Call on Wednesday, May 6, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0ae0f3b1-6350-4b75-a338-ef3bc512c976/small/kadant-logo-blk-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909396244-ufp-technologies-to-report-first-quarter-2026-financial-results-on-may-4-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T17:03:28+00:00</news:publication_date>
        <news:title>UFP Technologies to Report First Quarter 2026 Financial Results on May 4, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ada06f8d-68b5-45e8-9d08-9589d61e57b6/small/ufp-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909395966-option-care-health-inc-investors-should-contact-block-leviton-to-find-out-how-they-might-recover-money-through-the-firm-s-investigation</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T16:52:38+00:00</news:publication_date>
        <news:title>Option Care Health, Inc. Investors Should Contact Block &amp; Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909389510-akamai-is-recognized-as-a-2026-gartner-peer-insights-customers-choice-for-api-protection</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T16:14:10+00:00</news:publication_date>
        <news:title>Akamai Is Recognized as a 2026 Gartner® Peer Insights™ Customers’ Choice for API Protection</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909360691-genetically-modified-foods-market-to-reach-451-60-billion-by-2030-driven-by-global-food-security-demands</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T14:21:00+00:00</news:publication_date>
        <news:title>Genetically Modified Foods Market to Reach $451.60 Billion by 2030, Driven by Global Food Security Demands</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909355749-psychemedics-releases-2026-workforce-insights-report</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T14:00:00+00:00</news:publication_date>
        <news:title>Psychemedics Releases 2026 Workforce Insights Report</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b2b4d705-cbfa-4454-b34d-791c4cc1a95d/small/psychemdicslogo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909346313-alkeus-pharmaceuticals-announces-presentation-of-gildeuretinol-data-during-the-association-for-research-in-vision-and-ophthalmology-arvo-2026-annual</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T13:00:00+00:00</news:publication_date>
        <news:title>Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fd46716f-cd58-41ed-99f3-9c111a393d15/small/alkeus-pharma-logo-2024-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909346422-ernexa-therapeutics-announces-1-for-25-reverse-stock-split</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T13:00:00+00:00</news:publication_date>
        <news:title>Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909341123-vicarious-surgical-reports-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T12:30:00+00:00</news:publication_date>
        <news:title>Vicarious Surgical Reports First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YWM2NTM0NGItOThhNS00OTcxLTg0NjctZjY2MTlkZjMwMTZkLTEyMTM5OTQtMjAyNi0wNC0zMC1lbg==/tiny/Vicarious-Surgical.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909341127-microbot-medical-announces-the-addition-of-senior-commercial-executive-with-proven-track-record-to-accelerate-commercial-readiness-in-europe-the</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T12:30:00+00:00</news:publication_date>
        <news:title>Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909336963-kadant-completes-acquisition-of-voestalpine-b-hler-profil</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T12:15:29+00:00</news:publication_date>
        <news:title>Kadant Completes Acquisition of voestalpine BÖHLER Profil</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0ae0f3b1-6350-4b75-a338-ef3bc512c976/small/kadant-logo-blk-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909336141-elicio-therapeutics-to-present-at-the-bank-of-america-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T12:00:00+00:00</news:publication_date>
        <news:title>Elicio Therapeutics to Present at the Bank of America Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d588dddd-266e-4f3e-930a-d4c5ba15fe31/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909336338-solid-biosciences-to-showcase-a-large-presence-at-the-29th-annual-meeting-of-the-american-society-of-gene-and-cell-therapy</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T12:00:00+00:00</news:publication_date>
        <news:title>Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909321723-uniqure-announces-successful-uk-mhra-pre-submission-meeting-for-amt-130-in-huntington-s-disease</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T11:05:00+00:00</news:publication_date>
        <news:title>uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2ba61fe2-12e5-4a01-afe1-419652b31512/small/logo-uniqure-ms-word-orange-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909321691-kymera-therapeutics-announces-first-quarter-2026-financial-results-and-provides-a-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T11:00:00+00:00</news:publication_date>
        <news:title>Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909312718-power-infrastructure-for-data-centers-market-to-reach-47-3-billion-by-2030-driven-by-ai-intensive-computing-expansion</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T10:12:24+00:00</news:publication_date>
        <news:title>Power Infrastructure for Data Centers Market to Reach $47.3 Billion by 2030, Driven by AI-Intensive Computing Expansion</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.baystatetimes.com/article/909303520-boston-teens-put-years-of-leadership-training-into-action-build-classrooms-in-panama</loc>
      <news:news>
        <news:publication>
          <news:name>Bay State Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-30T09:27:00+00:00</news:publication_date>
        <news:title>Boston Teens Put Years of Leadership Training into Action, Build Classrooms in Panama</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fb3f8b01-c5f2-42e3-bf6b-5139a9da3848/small/logo-school-the-world-color-vertical-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
